Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)

ClinicalTrials.gov ID: NCT01521663

Public ClinicalTrials.gov record NCT01521663. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 6:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)

Study identification

NCT ID
NCT01521663
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Impax Laboratories, LLC
Industry
Enrollment
159 participants

Conditions and interventions

Interventions

  • IPX159 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2011
Primary completion
Jan 31, 2013
Completion
Jan 31, 2013
Last update posted
Jan 31, 2017

2011 – 2013

United States locations

U.S. sites
38
U.S. states
20
U.S. cities
37
Facility City State ZIP Site status
University of Alabama at Birmingham Brimingham Alabama 35294
Preferred Research Partners, Inc. Little Rock Arkansas 72211
Scripps Clinic La Jolla California 92037
Collaborative Neuroscience Network, Inc. Long Beach California 90806
The Research Center of Southern California Oceanside California 92056
Stanford Center for Human Sleep Research Redwood City California 94063
Neurological Research Institute Santa Monica California 90404
Sleep-Alertness Disorder Center Aurora Colorado 80012
PAB Clinical Research Brandon Florida 33511
MD Clinical Hallandale Florida 33009
Neurology Associates of Ormond Beach Ormond Beach Florida 32174
Resurgence Group Palm Harbor Florida 34684
NeuroTrials Research Inc Atlanta Georgia 30342
Georgia Health Sciences University Augusta Georgia 30912
SleepMed of Central Georgia Macon Georgia 31201
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
Community Research Crestview Hills Kentucky 41017
Kentucky Research Group Louisville Kentucky 40217
Johns Hopkins Bayview Medical Center Campus Baltimore Maryland 21224
Sleep Health Centers, LLC Brighton Massachusetts 02135
Beacon Clinical Research, LLC Brockton Massachusetts 02301
QUEST Research Institute Farmington Hills Michigan 48334
Global Medical Institutes, LLC Princeton New Jersey 08540
Fieve Clinical Research, Inc. New York New York 10168
Comprehensive Multiple Sclerosis Care Center Patchogue New York 11772
Raleigh Neurology Associates, P.A. Raleigh North Carolina 27607
Wake Research Associates, LLC Raleigh North Carolina 27612
PMG Research of Wilmington, LLC Wilmington North Carolina 28401
Community Research Cincinnati Ohio 45255
Sleep Lab of Northeastern Pennsylvania Clarks Summit Pennsylvania 18411
SleepMed of SC Columbia South Carolina 29201
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464
University of Tennesee Health Science Center Memphis Tennessee 38163
Future Research Trials of Neurology Austin Texas 78731
Clinical Trial Network Houston Texas 77074
Bhupesh Dihenia, M.D., P.A. Lubbock Texas 79410
Paragon Research Center, LLC San Antonio Texas 78205
Sleep Medicine Associates Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01521663, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 31, 2017 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01521663 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →